Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Emergent BioSolutions Inc. Director's Dealing 2024

Feb 28, 2024

32870_dirs_2024-02-27_d347cf16-fe44-47bb-9be8-77eca7081024.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2024-02-23

Reporting Person: Williams Paul Anthony (SVP, Products Business)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-23 Common Stock F 105 $2.74 Disposed 25469 Direct

Footnotes

F1: Represents shares of common stock withheld to pay taxes.